2018
DOI: 10.1016/j.microrel.2018.06.017
|View full text |Cite
|
Sign up to set email alerts
|

Performance assessment of the NIRS-based medical system of evaluating therapeutic effect

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 26 publications
0
3
0
Order By: Relevance
“…As the change in concentration becomes smaller, the step between two adjacent steps shrinks. Until the injection of 0.2 mL, the step of optical density (ΔOD) variation disappears and a relatively stable rising line is realized [ 24 ]. As seen from the experiments, the device can detect a 1% change in blood volume, demonstrating a high level of sensitivity.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…As the change in concentration becomes smaller, the step between two adjacent steps shrinks. Until the injection of 0.2 mL, the step of optical density (ΔOD) variation disappears and a relatively stable rising line is realized [ 24 ]. As seen from the experiments, the device can detect a 1% change in blood volume, demonstrating a high level of sensitivity.…”
Section: Resultsmentioning
confidence: 99%
“…The overall compact structure of the device is only 43 mm × 12 mm × 1.8 mm in size and 1.6 g in mass ( Figure S1 ). Compared with other fNIRS systems, it has the characteristics of ultrathin and ultra-soft properties, greatly improving wear comfort [ 24 ].…”
Section: Methodsmentioning
confidence: 99%
“…Second, it is important to note that all the information contained in NeurorehAPP will never be a substitute for professional healthcare. Further, our mobile application does not include information about the application of optical technology in the field of health care [ 31 ] or other technologies added [ 32 ], so future designs should consider these aspects. Third, although our app could be useful in addressing certain neurological diseases, its use would not always be applicable in cases where there is a cognitive impairment that hinders the understanding of the guidelines set by the application itself or in patients with motor deficits that limit the interaction with the app.…”
Section: Discussionmentioning
confidence: 99%